Education
About Us
Working with TipRanks
Follow Us
Inspire Medical Systems (INSP)
NYSE:INSP
Total Valuation
Inspire Medical Systems has a market cap or net worth of $2.71B. The enterprise value is $3.56B.
Market Cap$2.71B
Enterprise Value$3.56B
Share Statistics
Inspire Medical Systems has 29,574,316 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,574,316
Owned by Insiders0.98%
Owned by Institutions1.85%
Financial Efficiency
Inspire Medical Systems’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.58%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)4.58%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee644.30K
Profits Per Employee42.94K
Employee Count1,246
Asset Turnover0.99
Inventory Turnover1.54
Valuation Ratios
The current PE Ratio of Inspire Medical Systems is 53.5. Inspire Medical Systems’s PEG ratio is ―.
PE Ratio53.5
PS Ratio―
PB Ratio―
Price to Fair Value8.00
Price to FCF―
Price to Operating Cash Flow21.95
PEG Ratio―
Income Statement
In the last 12 months, Inspire Medical Systems had revenue of 802.80M and earned 53.51M in profits. Earnings per share was 1.80.
Revenue802.80M
Gross Profit679.82M
Operating Income36.08M
Pretax Income58.45M
Net Income53.51M
EBITDA65.03M
Earnings Per Share (EPS)1.80
Cash Flow
In the last 12 months, operating cash flow was 117.44M and capital expenditures -32.44M, giving a free cash flow of 85.01M billion.
Operating Cash Flow117.44M
Free Cash Flow85.01M
Free Cash Flow per Share2.87
Dividends & Yields
Inspire Medical Systems pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change-49.68%
50-Day Moving Average114.62
200-Day Moving Average156.52
Relative Strength Index (RSI)39.61
Average Volume (3m)1.30M
Important Dates
Inspire Medical Systems upcoming earnings date is Nov 4, 2025, After Close (Confirmed).
Last Earnings DateAug 4, 2025
Next Earnings DateNov 4, 2025
Ex-Dividend Date―
Financial Position
Inspire Medical Systems as a current ratio of 7.13, with Debt / Equity ratio of 4.88%
Current Ratio7.13
Quick Ratio6.22
Debt to Market Cap<0.01
Net Debt to EBITDA-1.82
Interest Coverage Ratio1.64K
Taxes
In the past 12 months, Inspire Medical Systems has paid 4.94M in taxes.
Income Tax4.94M
Effective Tax Rate0.08
Enterprise Valuation
Inspire Medical Systems EV to EBITDA ratio is 83.03, with an EV/FCF ratio of 59.25.
EV to Sales6.73
EV to EBITDA83.03
EV to Free Cash Flow59.25
EV to Operating Cash Flow41.45
Balance Sheet
Inspire Medical Systems has $300.89M in cash and marketable securities with $33.06M in debt, giving a net cash position of -$267.84M billion.
Cash & Marketable Securities$300.89M
Total Debt$33.06M
Net Cash-$267.84M
Net Cash Per Share-$9.06
Tangible Book Value Per Share$23.17
Margins
Gross margin is 84.47%, with operating margin of 4.49%, and net profit margin of 6.67%.
Gross Margin84.47%
Operating Margin4.49%
Pretax Margin7.28%
Net Profit Margin6.67%
EBITDA Margin8.10%
EBIT Margin7.28%
Analyst Forecast
The average price target for Inspire Medical Systems is $158.29, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$158.29
Price Target Upside71.50% Upside
Analyst ConsensusModerate Buy
Analyst Count18
Revenue Growth Forecast22.05%
EPS Growth Forecast785.52%